And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, once again, is unsurprisingly modest. We plan to take a few naps, promenade with the official mascot, and take a few more naps. And what about you? This may be a good time to stimulate the economy and order some takeout from a favorite eatery. You could spend some time in front of the telly. Or you could reach out to someone feeling isolated. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …
An Israeli study found that a single shot of the Covid-19 vaccine from Pfizer (PFE) and BioNTech (BNTX) is 85% effective in preventing symptomatic disease 15 to 28 days after being administered, a development that could help guide policy makers setting vaccine priorities worldwide, The Wall Street Journal says. The study also found a 75% drop in all Covid-19 infections after the first shot. The peer-reviewed study was published in the Lancet as a correspondence, meaning it represents the views of the authors and not the medical journal.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
What is it?
STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What’s included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
